BGMD OTC
BG Medicine, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -99.5%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
+55.1% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$4M
+55.1% ▲
Dividends Paid
$2M
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$3M
+28.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $0 | -$24M | -$16M | -$8M | -$5M |
| Depreciation & Amort. | $420K | $273K | $165K | $131K | $87K |
| Stock-Based Comp. | $2M | $2M | $1M | $671K | $831K |
| Change in Working Capital | $199K | -$385K | -$1M | -$1M | -$24K |
| Other Non-Cash Items | -$17M | $188K | $602K | $222K | $742K |
| Operating Cash Flow | -$15M | -$21M | -$15M | -$8M | -$4M |
| — Investing Activities — | |||||
| Capital Expenditures | -$93K | -$85K | -$132K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $13K |
| Investment Purchases | -$16M | $0 | $0 | $0 | $0 |
| Investment Sales | $16M | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$85K | $100K | $0 | $13K |
| Investing Cash Flow | -$93K | -$85K | -$32K | $0 | $13K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$100K | $10M | -$3M | -$4M | -$3M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | -$2M |
| Other Financing | -$825K | $330K | -$240K | -$219K | $4M |
| Financing Cash Flow | $37M | $10M | $10M | $5M | $1M |
| Net Change in Cash | $21M | -$11M | -$5M | -$4M | -$3M |
| Cash End of Period | $24M | $13M | $8M | $4M | $2M |
| Free Cash Flow | -$15M | -$21M | -$15M | -$8M | -$4M |